Article
The emerging role of histone lysine demethylases in prostate cancer
1 Jan 2012
Abstract excerpt
Early prostate cancer (PCa) is generally treatable and associated with good prognosis. After a variable time, PCa evolves into a highly metastatic and treatment-refractory disease: castration-resistant PCa (CRPC). Currently, few prognostic factors are available to predict the emergence of CRPC, and no curative option is available. Epigenetic gene regulation has been shown to trigger PCa metastasis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
